100 related articles for article (PubMed ID: 4016782)
1. Acute ECG changes during cyclophosphamide infusion in a patient with bronchogenic carcinoma.
Shachor J; Beker B; Geffen Y; Bruderman I
Cancer Treat Rep; 1985 Jun; 69(6):734-5. PubMed ID: 4016782
[No Abstract] [Full Text] [Related]
2. [Trials of synchronized attack drug therapy in bronchogenic carcinoma].
Seccia A; Scafuri L; Scognamillo A; Cocco G
G Ital Chemioter; 1975; 22(1-2):63-6. PubMed ID: 1235355
[No Abstract] [Full Text] [Related]
3. [Early results of bronchogenic carcinoma treatment with massive doses of cyclophosphamide].
Kochnowski G; Rozek G; Wisńiewski J
Wiad Lek; 1976 Feb; 29(4):270-1. PubMed ID: 1251645
[No Abstract] [Full Text] [Related]
4. Cyclophosphamide (NSC-26271) as adjuvant to radiotherapy in the treatment of unresectable bronchogenic carcinoma.
Host H
Cancer Chemother Rep 3; 1973 Mar; 4(2):161-4. PubMed ID: 4729319
[No Abstract] [Full Text] [Related]
5. Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
Brunner KW; Marthaler T; Müller W
Cancer Chemother Rep 3; 1973 Mar; 4(2):125-32. PubMed ID: 4199643
[No Abstract] [Full Text] [Related]
6. Ifosfamide in the treatment of bronchogenic carcinoma. A preliminary trial.
Gandola L; Pozzi E; Tansini G
G Ital Chemioter; 1978; 25(1):41-4. PubMed ID: 376387
[No Abstract] [Full Text] [Related]
7. Phase II study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma.
Pisoni MB; Libretti A; Piazza E; Vago G; Scapaticci R; Bianchi C; Tomirotti M; Scanni A; Calzavara MP; Cassani L; Scarpazza G; Marsoni S; Morasca L
Cancer Treat Rep; 1981; 65(7-8):731-2. PubMed ID: 6788372
[No Abstract] [Full Text] [Related]
8. 5-Fluorouracil (NSC-19893) compared to cyclophosphamide (NSC-26271) in bronchogenic carcinoma: results of a clinical study.
Brugarolas A; Rivas A; Lacave AJ; Gonzalez-Palacois F; Froufe A
Cancer Chemother Rep; 1975; 59(5):1025-6. PubMed ID: 1106844
[No Abstract] [Full Text] [Related]
9. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
Athanassiades P; Lagoudis M; Kostis E
J Chemother; 1989 Jul; 1(4 Suppl):1205-6. PubMed ID: 16312835
[No Abstract] [Full Text] [Related]
10. [Value of polychemotherapy for bronchogenic carcinoma other than undifferentiated small cell carcinoma].
Laberge F; Desmeules M; Bergeron D; La Forge J; Cormier Y
Union Med Can; 1984 Mar; 113(3):222-4. PubMed ID: 6730096
[No Abstract] [Full Text] [Related]
11. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
[No Abstract] [Full Text] [Related]
12. [Polychemotherapy of bronchial carcinoma].
Fazio M; Minetto E; Cavallero P; Sartoris S
Minerva Med; 1970 Jun; 61(46):2567-70. PubMed ID: 5425737
[No Abstract] [Full Text] [Related]
13. Cytoxan therapy in the treatment of carcinoma of the lung. (Report of a five-year survival).
Castro L
W V Med J; 1974 Jun; 70(6):131-5. PubMed ID: 4524737
[No Abstract] [Full Text] [Related]
14. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
[No Abstract] [Full Text] [Related]
15. Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group.
Karrer K; Pridun N; Zwintz E
Cancer Chemother Rep 3; 1973 Mar; 4(2):207-13. PubMed ID: 4729324
[No Abstract] [Full Text] [Related]
16. Prinzmetal's Variant Angina during cis-diamminodichloroplatinum (CDDP) administration: case report.
Oliva S; Mannarini A; Giotta F; Colucci G; Calabrese P
J Chemother; 2003 Feb; 15(1):89-90. PubMed ID: 12678422
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
Denes AE; Presant CA; Bartolucci A
Cancer Treat Rep; 1982 Jan; 66(1):199-200. PubMed ID: 7053258
[No Abstract] [Full Text] [Related]
18. Bronchial artery infusion therapy for unresectable bronchogenic carcinoma.
Kimura S; Neyazaki T; Suzuki C
Panminerva Med; 1975; 17(9-10):337-8. PubMed ID: 1230740
[No Abstract] [Full Text] [Related]
19. [Cytostatic therapy of tumors of the lung].
De Marco F; Saviano G; Tenore G
Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
[No Abstract] [Full Text] [Related]
20. Aclarubicin given as continuous infusion in non-small cell bronchogenic carcinoma.
Chiuten DF; Umsawasdi T; Dhingra HM; Bodey GP; Valdivieso M
Cancer Treat Rep; 1985 Nov; 69(11):1327-8. PubMed ID: 3867406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
